About Tafero EM tablet
Tafero EM tablet contains the active ingredient Emtricitabine/ tenofovir alafenamide. It is a combination of antiretroviral medication. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). It is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age and who weigh at least 35kg. They work by slowing the spread of HIV in the body.Do not take Tafero EM tablet if you are allergic to Emtricitabine/ tenofovir alafenamide or any of the other ingredients. Get tested for HIV infection regularly while using this medicine. Do not miss any doses of this medicine or stop taking it. Missing doses may increase your risk of getting HIV infection. This medicine does not prevent other sexually transmitted infections (STIs). Inform your physician if you have liver problems or suffer from liver disease, including hepatitis, kidney problems, and bone problems. Do not give this medicine to children aged 11 years or under. Convenient Daily Oral TherapyTafero EM tablets offer a simple, once-daily oral dosage regimen, making HIV-1 treatment and prevention easier to adhere to. The film-coated tablets are designed for adult use, providing essential antiviral action with minimal disruption to daily routines.
Reliable Allopathic FormulaCombining Tenofovir Alafenamide and Emtricitabine, Tafero EM delivers effective antiviral action against HIV-1 infection. These tablets are distributed in India by Hetero Healthcare Ltd., ensuring quality and reliability for individuals under medical supervision.
Safety, Storage, and ComplianceThis medication is dispensed only via prescription and must be stored below 30C, protected from moisture and light, to maintain its efficacy. The 24-month shelf life offers flexibility, while the HDPE bottle provides safe and practical packaging for ongoing use.
FAQ's of Tafero EM tablet:
Q: How should Tafero EM tablets be taken for HIV treatment or prevention?
A: Tafero EM tablets are to be taken orally, once daily, either with or without food, as directed by your physician. Do not adjust the dosage or discontinue use without consulting your doctor.
Q: What is the main benefit of using Tafero EM tablets?
A: Tafero EM provides effective antiviral therapy for HIV-1 infection, helping to control the virus and prevent progression of the disease when taken regularly as prescribed.
Q: When is Tafero EM prescribed and who is it suitable for?
A: Tafero EM is prescribed for adults diagnosed with HIV-1 infection for treatment or prevention purposes. It should only be used with a valid prescription from a registered medical practitioner.
Q: What are common side effects associated with Tafero EM tablets?
A: The commonly reported side effects include headache, abdominal pain, fatigue, diarrhea, and nausea. If you experience any severe or unusual symptoms, notify your healthcare provider promptly.
Q: Where should Tafero EM tablets be stored to maintain their effectiveness?
A: Store Tafero EM tablets in their HDPE bottle at a temperature not exceeding 30C, away from light and moisture, to preserve their quality throughout the shelf life.
Q: What process should be followed to obtain Tafero EM?
A: Tafero EM can only be obtained through a registered pharmacy, with a valid prescription from a certified medical practitioner, as per Indian regulations.
Q: What ingredients does Tafero EM contain and what is its physical form?
A: Tafero EM contains Tenofovir Alafenamide 25mg and Emtricitabine 200mg per tablet, and is available as white to off-white, film-coated tablets, supplied in bottles of 30.